Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SGCE | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
mRNA | RCVRN | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
mRNA | SPRY2 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | HAUS2 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | RMI1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | ECE1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | TH | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | SNX4 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | PAM16 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | ARL5A | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |